NCT01568164 - Safety and Efficacy Study of the BioVentrix PliCath HF System | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions

Heart Failure

Interventions

DEVICE

PliCath HF System

This study is a multi-center, prospective, single-armed, study designed to evaluate the safety and efficacy of the BioVentrix PliCath HF System for left ventricular volume restoration in patients with ischemic cardiomyopathy.

Trial Locations (19)

87

Azienda Ospedaliera S.Camillo-Forlanini, Rome

602

Medical University Innsbruck, Innsbruck

1503

NA Holmoce Hospital, Prague

10126

Ospedale Le Molinetto, Torino

17674

Onassis Cardiac Surgery Center, Athens

20097

IRCCS Istituto Policlinico San Donato, Milan

20132

Ospedale San Raffaele, Milan

33604

Bordeaux University Hospital Cardiology, Bordeaux

75013

Hospital Pitie Sal Petirere Institute of Cardiology, Paris

1 25123

Spedali Civili di Cardiochirurgia, Brescia

I-35128

Padova University Hospital, Padua

Unknown

Pauls Stradins Clinical University, Riga

Hospital Clinic and University of Barcelona, Barcelona

08661

Vilnius Hospital Santariskiu Klinikus, Vilnius

40-534

Polish American Hospital, Katowice

31-202

Jagiellonian University, Krakow

4434-502

CHVNGaia / Espinho Hospital, Porto

SE594S

Kings College Hospital, London

SW36NP

The Royal Brompton Hospital, London